Compile Data Set for Download or QSAR
Report error Found 104 Enz. Inhib. hit(s) with all data for entry = 13055
TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755339BDBM755339((R)-2-((S)-2-(4-((3-aminopropyl)amino)isoindolin-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755337BDBM755337((R)-2-((S)-2-(4-(3-aminopropoxy)phenyl)-2-(isoindo...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755336BDBM755336((R)-2-((S)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755335BDBM755335((R)-2-((S)-2-(4-(3-aminopropoxy)phenyl)-2-(isoindo...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755334BDBM755334((R)—N-(2,6-difluoro-4-hydroxybenzyl)-2-((R)-2-(iso...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755333BDBM755333((R)—N-(2,6-difluoro-4-hydroxybenzyl)-2-((S)-2-(iso...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755345BDBM755345((R)—N-(2,6-difluoro-4-hydroxybenzyl)-5-guanidino-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755343BDBM755343((2R)—N-(2,6-difluoro-4-hydroxybenzyl)-5-((Z)-2-(et...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755342BDBM755342((R)-2-((R)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755341BDBM755341((R)-2-((S)-2-(3-((3-aminopropyl)amino)phenyl)-2-(i...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755340BDBM755340((R)-2-((S)-2-(5-((3-aminopropyl)amino)isoindolin-2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755323BDBM755323(2,2',2″-(10-((14R,16R)-22-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755322BDBM755322(2,2',2″-(10-(2-((2-((2R,5R)-5-(2-((3-(4-((1S,4R,Z)...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755321BDBM755321(US20250213735, Compound 51)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755320BDBM755320(2,2',2″-(10-(2-((3-(((R)-4-amino-1-((3-(4-((1S,4R,...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755319BDBM755319(2,2',2″-(10-(4-((2-(4-((3-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755318BDBM755318(2,2',2″-(10-(2-((3-(((R)-1-((3-(4-((1S,4R,Z)-9-ami...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755317BDBM755317(2,2',2″-(10-(2-((3-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755316BDBM755316(US20250213735, Compound 46)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755331BDBM755331((R)—N-(4-hydroxybenzyl)-2-((S)-2-(isoindolin-2-yl)...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755330BDBM755330((2R)—N-(4-hydroxybenzyl)-2-(2-(isoindolin-2-yl)-2-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755329BDBM755329(2,2',2″-(10-(2-((3-(4-((1S,4R,Z)-9-amino-4-((4-hyd...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755328BDBM755328(2,2',2″-(10-(2-((6-((2-(4-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755327BDBM755327(2,2',2″-(10-(2-((6-((4-(4-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755326BDBM755326(2,2',2″-(10-(2-((5-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755325BDBM755325(2,2',2″-(10-(2-((2-((3-((3-(4-((1S,4R,Z)-9-amino-4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755324BDBM755324(2,2',2″-(10-((8R,11R,14R)-19-(4-((1S,4R,Z)-9-amino...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755371BDBM755371(US20250213735, Compound 92)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755370BDBM755370((2R)-2-(2-(4-(tert-butyl)piperidin-1-yl)-2-phenyla...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755275BDBM755275(US20250213735, Compound 6)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755274BDBM755274(2,2',2″-(10-(2-((6-(4-((3-(4-((1S,4R,Z)-9-amino-4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755273BDBM755273(US20250213735, Compound 4)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755272BDBM755272(2,2',2″-(10-(2-((6-((4-((3-((1R,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755271BDBM755271(2,2',2″-(10-(2-((6-((4-((3-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755270BDBM755270(2,2',2″-(10-(2-((6-((2-((3-((3-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755268BDBM755268(US20250213735, Compound 1A)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755283BDBM755283(2,2',2″-(10-(2-((2-(3-((3-((3-((11R,14S,Z)-6-amino...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755282BDBM755282(2,2',2″-(10-(2-(((R)-5-amino-6-((3-((3-((11R,14S,Z...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755281BDBM755281(2,2',2″-(10-(2-((6-((3-(3-((1S,4R,Z)-9-amino-4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755280BDBM755280(2,2',2″-(10-(2-((6-((3-((3-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755279BDBM755279(2,2',2″-(10-(9-((3-((2-((1S,4R,Z)-9-amino-4-((2,6-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755278BDBM755278(2,2',2″-(10-(2-((6-((4-((2-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755276BDBM755276(A single isomer of 2,2',2″-(10-(2-((2-(2-(3-(4-((4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755307BDBM755307(2,2',2″-(10-(2-((6-((2-((3-(4-((1S,4R,Z)-9-amino-4...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755306BDBM755306(2,2',2″-(10-(2-((6-((3-(4-((1S,4R,Z)-9-amino-4-((2...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755305BDBM755305(2,2',2″-(10-(2-((6-(4-(4-(3-(4-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755304BDBM755304(2,2',2″-(10-(2-((6-((2-((3-((2-((1S,4R,Z)-9-amino-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755303BDBM755303(2,2',2″-(10-(2-((6-((3-((2-((1S,4R,Z)-9-amino-4-((...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755302BDBM755302(A single isomer of 2,2',2″-(10-(2-((3-(((R)-1-((4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandChemical structure of BindingDB Monomer ID 755301BDBM755301(A single isomer of 2,2',2″-(10-(2-((3-(((R)-1-((4-...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent

Displayed 1 to 50 (of 104 total ) | Next | Last >>
Jump to: